Sign in
Enrolling by invitationNo phase

Building a patient group with Crohn disease or ulcerative colitis to predict outcomes

Builds a cohort of people with Crohn disease or ulcerative colitis to predict treatment response.

Key facts

Who runs it
Seoul National University Hospital
Where
Seoul, South KoreaSee the site
Trial code
Registry title
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Status
Enrolling by invitation
People taking part
2,000 people, planned
Started
20 Jan 2021
Expected to end
31 Dec 2028
Type of study
Observational
Record updated
15 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The study is looking for people aged 10 or older with inflammatory bowel disease (Crohn disease or ulcerative colitis), newly diagnosed or already in follow-up.

Age
10 years or older
Sex
All sexes
Disease stage
Inflammatory bowel disease, either newly diagnosed or under follow-up monitoring
Earlier treatment
Anyone with a history of cancer treatment cannot join.

Main reasons for not taking part

  • Diagnosed with cancer or has a history of cancer treatment
  • Under 10 years old
  • The medical team may decide that a person cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring

Who cannot take part

  • Patients diagnosed with cancer or with a history of cancer treatment
  • Infants and young children under the age of 10
  • Participation may be restricted at the discretion of the medical team

Where in South Korea

  • Seoul National University HospitalSeoul, South KoreaEnrolling by invitation

About the trial

What the trial wants to find out

This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Plain-language title
Building a patient group with Crohn disease or ulcerative colitis to predict outcomesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
15 September 2025